EBI3 and plasma cell myeloma: CD138+ plasma cells showed increased expression of IL10 and IL-27β compared to the less mature variant CD138int B cells suggesting regulatory functionality is gained through this maturation process [41]. CD138 suppresses apoptosis in multiple myeloma by activating IGF1 Receptor [42].